2026-10-20Neutral
-6.23%24 hours changeHHS's Kidney Care National Plan urged lower dialysis entry barriers; DaVita closed down 6.23% on 3.23x volume.
read the report →← every name covered
S&P 500
DVA
DaVita
latest move
-6.23%
2026-10-20
7 sessions · 2026-08-05 → 2026-10-20 · avg 17.15% · largest 24.36%
DaVita provides kidney dialysis services in the United States for patients with chronic kidney failure, operating outpatient dialysis centres, clinical laboratories, and home-based hemodialysis.
Price history
stitched from the price window carried by each report
Every session it moved
newest first2026-09-17Bullish
-5.56%24 hours changeShares fell due to heavy profit-taking after a recent surge, conservative analyst targets, and broader market interest rate anxiety.
read the report →2026-08-11Bearish
-21.78%weekly changeDaVita reported a full-year guidance midpoint that missed consensus estimates alongside sequential declines in revenue per treatment.
read the report →2026-08-10Bullish
-21.39%weekly changeDaVita fell after reaffirming full-year guidance despite Q2 beats, as ACA subsidy expirations caused margin compression.
read the report →2026-08-07Neutral
-23.46%weekly changeShares fell after Q2 earnings revealed margin compression, lower commercial payer mix from declining ACA enrollment, and flat guidance.
read the report →2026-08-06Neutral
-24.36%weekly changeThe stock fell after DaVita merely reaffirmed guidance despite Q2 beats and warned of lower revenue per treatment from payer mix shifts.
read the report →2026-08-05Neutral
-17.24%24 hours changeThe stock fell as Q2 revenue per treatment dropped from an adverse ACA payer mix shift and full-year EPS guidance was merely reconfirmed.
read the report →